[Are cardiac glycosides still needed in the treatment of cardiac insufficiency?].
Böhm
M
M
Med. Universitätsklinik und Poliklinik, Innere Medizin III, Homburg/Saar. boehm@med-in.uni.uni-saarland.de
D002301:Cardiac Glycosides / Q000627:therapeutic use*; D002316:Cardiotonic Agents / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D004077:Digoxin / Q000627:therapeutic use; D004280:Dobutamine / Q000627:therapeutic use; D006333:Heart Failure / Q000175:diagnosis / Q000188:drug therapy*; D006801:Humans; D015337:Multicenter Studies as Topic; D016017:Odds Ratio; D012306:Risk; D012720:Severity of Illness Index; D017211:Treatment Failure; D016896:Treatment Outcome
D002301:Cardiac Glycosides; D002316:Cardiotonic Agents; D004280:Dobutamine; D004077:Digoxin